Device Trial Radar · NCT05972889
Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP
Last checked: Nov 20, 2026Latest source record: Oct 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
334
Actual
Start
Nov 2, 2023
Primary completion
Oct 21, 2025
Study completion Oct 21, 2025
Sponsor
- Lead sponsor
- Zynex Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 2, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined standard of care for improvement of pain intensity of non-specific CLBP.
Conditions
- Non-Specific Chronic Lower Back Pain
Interventions
NexWaveDevice
Device subjects receive designated treatment mode twice daily for up to 8 weeks.
ShamDevice
Sham subjects provided with Sham Device and treatment instructions identical to that of NexWave Device Arm for their designated Sham Arm. Sham subjects participate for 4 weeks with the option to crossover to the NexWave Device Arm for an additional 4 weeks (up to 8 weeks total).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visual Analogue Scale Pain Rating - NexWave vs. ShamTime frame: Four weeks
1 more outcomes with a free account
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
DBPS Research
Greenwood Village, Colorado
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.